These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 5620280)

  • 1. [Etiopathogenesis of liver cirrhosis].
    Cerlek S
    Wien Z Inn Med; 1967; 48(5):196-203. PubMed ID: 5620280
    [No Abstract]   [Full Text] [Related]  

  • 2. TNF-alpha as therapeutic target in NASH: tried, but not yet proven.
    Chitturi S; Farrell GC
    J Gastroenterol Hepatol; 2007 May; 22(5):613-4. PubMed ID: 17444846
    [No Abstract]   [Full Text] [Related]  

  • 3. [Sequelae of viral hepatitis. Morphological evaluation].
    Weisz P; Niederland TR; Zacharová M; Cervenka J; Tomík F
    Cesk Gastroenterol Vyz; 1975 Jul; 29(5):297-301. PubMed ID: 1157118
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical and experimental studies of liver injury in diabetes mellitus. I. Clinical studies.
    Takeuchi J; Takada A; Nakada Y; Ebata K
    Acta Hepatosplenol; 1970; 17(3):137-51. PubMed ID: 5421886
    [No Abstract]   [Full Text] [Related]  

  • 5. [Some causes of transition of Botkin's disease in to cirrhosis and dystrophy of the liver].
    Kazazian AV
    Zh Eksp Klin Med; 1966; 6(4):93-100. PubMed ID: 6003243
    [No Abstract]   [Full Text] [Related]  

  • 6. Liver disease and alcohol: fatty liver, alcoholic hepatitis, cirrhosis, and their interrelationships.
    Lieber CS
    Ann N Y Acad Sci; 1975 Apr; 252():63-84. PubMed ID: 50030
    [No Abstract]   [Full Text] [Related]  

  • 7. Liver cirrhosis and diabetes mellitus.
    Muting D; Wohlgemuth D; Dorsett R
    Geriatrics; 1969 Jan; 24(1):91-9. PubMed ID: 5782543
    [No Abstract]   [Full Text] [Related]  

  • 8. Is past exposure to hepatitis A protective against progressive fibrosis in non-alcoholic fatty liver disease?
    de Silva AP; Kasturiratne A; Liyanage DL; Karunanayaka TK; de S Hewavisenthi SJ; Dassanayake AS; Farrell GC; de Silva HJ
    Liver Int; 2008 Jan; 28(1):147-9. PubMed ID: 18173565
    [No Abstract]   [Full Text] [Related]  

  • 9. [Non-alcoholic steatohepatitis. Presentation of a case with development into hepatic cirrhosis].
    Valdes Oliveras M; Oristrell Salva J; Allende Monclus E; Bosch Gil JA
    Rev Esp Enferm Apar Dig; 1985 Oct; 68(4):363-5. PubMed ID: 4081262
    [No Abstract]   [Full Text] [Related]  

  • 10. [Development of fatty liver].
    Cohen J
    Prensa Med Argent; 1970 Jul; 57(20):991-4. PubMed ID: 5471515
    [No Abstract]   [Full Text] [Related]  

  • 11. Drugs and their abuse. VI. Misuse of drugs in liver disease.
    McCarthy CF
    J Ir Med Assoc; 1971 Aug; 64(417):409-10. PubMed ID: 5562384
    [No Abstract]   [Full Text] [Related]  

  • 12. [Liver cirrhosis and alcohol].
    Rev Clin Esp; 1968 Jul; 110(1):79-80. PubMed ID: 5735079
    [No Abstract]   [Full Text] [Related]  

  • 13. [Lesions in nanolcoholic fatty liver disease].
    Bedossa P
    Rev Prat; 2012 Dec; 62(10):1419. PubMed ID: 23424925
    [No Abstract]   [Full Text] [Related]  

  • 14. [Non-alcoholic steatohepatitis: a controversial cause of liver cirrhosis].
    Guilarte López-Mañas J; Bellot García V; Gil Villa MM
    Gastroenterol Hepatol; 1997 Apr; 20(4):217. PubMed ID: 9280618
    [No Abstract]   [Full Text] [Related]  

  • 15. [Ultrastructure and liver function].
    Iturriaga Ruiz H
    Rev Med Chil; 1969 Sep; 97(9):614-20. PubMed ID: 4921593
    [No Abstract]   [Full Text] [Related]  

  • 16. [Post-infective infantile cirrhosis].
    Madon E; Martini Mauri M
    Minerva Pediatr; 1968 Aug; 20(34):1716-29. PubMed ID: 5746681
    [No Abstract]   [Full Text] [Related]  

  • 17. Editorial: Fatty liver-steatonecrosis-cirrhosis.
    Thaler H
    Acta Hepatogastroenterol (Stuttg); 1975 Oct; 22(5):271-3. PubMed ID: 1199665
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinico-morphological dynamics of chronic diffuse liver diseases].
    Loginov AS; Blok IuE; Shepeleva SD; Tkachev VD
    Ter Arkh; 1981; 53(11):50-9. PubMed ID: 7339906
    [No Abstract]   [Full Text] [Related]  

  • 19. Liver diseases and diabetes mellitus.
    Creutzfeldt W; Frerichs H; Sickinger K
    Prog Liver Dis; 1970; 3():371-407. PubMed ID: 4908707
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of sirepar on experimental cirrhosis in rats.
    Szarvas F; Biliczki F
    Ther Hung; 1970; 18(3):103-6. PubMed ID: 5496809
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.